Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Bio-Strategy Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (56)
ARTG (27)

Date

2024 (3)
2023 (7)
2022 (20)
2021 (10)
2020 (10)
2019 (9)
2018 (3)
2017 (15)
2014 (3)
2013 (2)
2012 (1)

Results for "[search-keyword]"

Search

Sponsor content

83 result(s) found, displaying 21 to 30

Bio-Strategy Pty Ltd- Clinical chemistry-specific protein IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd- Multiple HLA/HNA/HPA typing antigen/antibody IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd- Multiple human leukocyte antigen (HLA) antibodies IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd- Human leukocyte antigen A (HLA-A) typing sera IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd - Interpretive software IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd - Multiple human leukocyte antigens (HLA) typing IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd - Interpretive software IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd - Human leukocyte antigen DP (HLA-DP) typing sera IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd - Human leukocyte antigen DQ (HLA-DQ) typing sera IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd - Tissue typing-related IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.